Emily Arsenault, MD
Dermatology · Lakewood Ranch, FLNPI 1972513109
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.8%), food and beverage and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 72.8% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $3,567, 5.6 times the $642 reported in 2019.
Across 154 payments — averaging $66.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Johnson & Johnson$314
- UCB, Inc.$287
- Regeneron Healthcare Solutions, Inc.$261
- LEO Pharma Inc.$224
- Dermavant Sciences, Inc.$177
- plus $2K from 19 others
What the payments were for
- Speaking & faculty fees$6,14360%
- Food & beverage$4,04939%
- Education$861%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 103 | $7,483 |
| Johnson & Johnson | 4 | $314 |
| UCB, Inc. | 3 | $287 |
| Regeneron Healthcare Solutions, Inc. | 3 | $261 |
| LEO Pharma Inc. | 6 | $224 |
| Dermavant Sciences, Inc. | 3 | $177 |
| Genentech USA, Inc. | 4 | $156 |
| Pfizer | 3 | $154 |
| Arcutis Biotherapeutics, Inc. | 1 | $146 |
| Novartis | 2 | $136 |
| Sun Pharmaceutical Industries Inc. | 2 | $124 |
| Lilly USA, LLC | 1 | $123 |
| Verrica Pharmaceuticals Inc. | 1 | $122 |
| E.r. Squibb & Sons, L.L.C. | 1 | $116 |
| Janssen Scientific Affairs, LLC | 1 | $110 |
| Sandoz | 4 | $73 |
| Organogenesis Inc. | 1 | $63 |
| Dermira, Inc. | 2 | $40 |
| Aclaris Therapeutics, Inc. | 2 | $38 |
| DUSA Pharmaceuticals, Inc. | 2 | $27 |
| Amgen | 1 | $25 |
| Biofrontera Inc. | 1 | $23 |
| Boston Scientific | 1 | $21 |
| Promius Pharma LLC | 1 | $20 |
| Glenmark Therapeutics Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,278 in reported general payments places this provider in the 80th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 90 | $5,856 |
| Clobetasol Propionate | 67 | $3,241 |
| Ketoconazole | 131 | $2,550 |
| CiclopiroxCiclopirox Olamine | 39 | $1,037 |
| Metronidazole | 11 | $674 |
| Hydrocortisone | 107 | $529 |
| ValacyclovirValacyclovir Hcl | 28 | $495 |
| Hydrocortisone Valerate | 15 | $445 |
| Triamcinolone Acetonide | 73 | $433 |
| Ciclopirox | 14 | $422 |
| Doxycycline Hyclate | 25 | $371 |
| Minocycline Hcl | 21 | $165 |
| Mupirocin | 21 | $137 |
| Terbinafine Hcl | 17 | $64 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Lakewood Ranch
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
- Mercedes GonzalezMiami$943K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.